Please login to the form below

Not currently logged in
Email:
Password:

Leo Pharma appoints Geraldine Murphy as UK and Ireland MD

She takes over from Dennis Dencher, who takes up regional post at the company

Leo Pharma UK & Ireland MD Geraldine Murphy Leo Pharma has appointed Geraldine Murphy as managing director for the UK and Ireland, filling the post vacated by Dennis Dencher.

Dencher left the MD role last month to move to a new role at Leo as regional director for mid-north Europe, where he will have responsibility for the dermatology specialist's affiliates in the Nordic and Benelux regions and Poland.

The appointment of Murphy follows Leo's recent global restructure in April that saw widen its focus from Northern Europe to the major global markets.

Murphy moves into the new role from within Leo, where she previously served as regional VP for the North Atlantic region (UK, Canada and Ireland), and has over 20 years of sales, marketing and commercial experience. During this time she also worked at Fisons and Elan.

In her new position, Murphy will report to Joergen Damsbo Andersen, regional VP, sales and marketing Leo Pharma.

Commenting on her new role Murphy said: “I am delighted to be taking charge of the UK & Ireland affiliates at this exciting time. We have a fantastic opportunity to share experiences between our two countries and work closely together to be the preferred dermatology care partner.”

1st August 2012

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Health Unlimited

Health Unlimited is part of Creston Unlimited (www.creston-unlimited.com), bringing together consultants and discipline experts from across the group and beyond....

Latest intelligence

The patient will see you now
GCI Health’s Laura Starr and Chris Bath report on how the dawning era of mobile tech and the ‘Internet of Things’ has transformed the health and wellness arena....
When forecasters take the floor: 6 tips on presenting a forecast
Peter Mansell queries some of pharma’s leading forecasters for their dos and don’ts on presenting a forecast...
Enablers of drug innovation could lie in the numbers
Christopher Ehinger of Black Swan Analysis addresses the problem of clinical-trial recruitment as a barrier to new drug development and offers a new way of looking at the problem....

Infographics